{"id":"c79f9ffb70fb","type":"article","url":"https://hartvaat.nl/2026/02/12/niet-langer-vergeten-lymfevaten-in-het-afstotende-transplantaat/","title":"Niet langer vergeten: lymfevaten in het afstotende transplantaat","title_en":"Neglected no longer: lymphatic vessels in the rejecting allograft","category":"chronische nierziekte","category_label":"Nierziekte","professions":["internist"],"tags":[],"journal":"Kidney International","doi":"https://www.kidney-international.org/article/S0085-2538(26)00074-8/fulltext","source_url":"https://doi.org/https://www.kidney-international.org/article/S0085-2538(26)00074-8/fulltext","authors":["Griffith B. Perkins","Maarten Naesens"],"significance":4,"published":"2026-02-12","source_date":"2026-02-12","image":"","kennis":[],"congress":"","summary_en":"This article highlights the previously neglected role of lymphatic vessels in kidney allograft rejection. As transplant pathologies become more complex, understanding lymphatic contributions may improve long-term graft outcomes.","created":"2026-07-03T10:25:22Z","updated":"2026-07-03T13:24:48Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Naarmate kortetermijnuitkomsten na niertransplantatie verbeteren, worden de oorzaken van transplantaatverlies complexer. Laat transplantaatverlies is vaak multifactorieel. Dit artikel belicht de tot nu toe verwaarloosde rol van lymfevaten bij transplantaatafstoting.","abstract_original":"As short-term kidney transplant outcomes have improved, and donor and recipient demographics have shifted, the causes of allograft loss have become more complex. Late graft loss (>1 year after transplant) is often caused by >1 factor, and rejecting grafts can exhibit complex pathologies. Understanding how complex pathologies, including mixed T-cell– and antibody-mediated rejection, arise in some transplant recipients, and why other recipients tolerate their transplants long-term, is important to now improve long-term outcomes."}